➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Moodys
McKinsey
Express Scripts
Medtronic

Last Updated: May 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Gensetix, Inc. v. Baylor College Of Medicine (S.D. Tex. 2017)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Gensetix, Inc. v. Baylor College Of Medicine (S.D. Tex. 2017)

Docket   Start Trial Date Filed 2017-04-03
Court District Court, S.D. Texas Date Terminated
Cause 35:271 Patent Infringement Assigned To Melinda Harmon
Jury Demand Plaintiff Referred To
Parties BAYLOR COLLEGE OF MEDICINE; DIAKONOS RESEARCH LTD; GENSETIX, INC.; THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM; WILLIAM K. DECKER
Patents 8,728,806
Attorneys Amy Pharr Hefley; Christopher Bruno; Donald Kreger; Elizabeth Durham Flannery; Gordon T Arnold; Imron T. Aly; Jeffrey Gritton; Lindsay Volpenhein Cutie; Murray J Fogler; Olin (Trey) Ray Hebert , III; Parvathi Kota; Paul J Skiermont; Paul Richard Morico; Peter Elton Mims; Robin Finney O'Neil; Sarah Elizabeth Spires
Firms Amy Pharr Hefley; Arnold, Knobloch & Saunders, LLP; Baker Botts LLP; Elizabeth Durham Flannery; Fogler, Brar, Ford, O'Neil & Gray LLP; Fogler, Brar, Ford, O'Neil & Gray, LLP; Schiff Harden LLP; Schiff Hardin LLP; Skiermont Derby LLP; Vinson & Elkins; Vinson & Elkins L.L.P.
Link to Docket External link to docket
Biologic Drugs cited in Gensetix, Inc. v. Baylor College Of Medicine
The biologic drug covered by the patent cited in this case is   Start Trial .

Details for Gensetix, Inc. v. Baylor College Of Medicine (S.D. Tex. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-06-23 26 cells. He patented those methods in United States Patent Nos. 8,728,806 (“the ’806 patent”) (Exhibit… and cites the ’806 patent for the following proposition: “U.S. Patent 8,728,806, which is incorporated…] cancer cell (see, e.g., U.S. Patent 8,728,806, which is incorporated herein … reference)”; b. “U.S. Patent 8,728,806, which is incorporated herein by reference…herein and in U.S. Patent 8,728,806.” 87. The ’475 application shows External link to document
2018-04-07 66 Gensetix accuses Defendants of infringing U.S. Patent Nos. 8,728,806 and 9,333,248 based on Decker’s research…to be discussed under the Local Patent Rules: A. Local Patent Rule 2-1(a) Disclosures …Gensetix alleges federal question jurisdiction for patent infringement, under Title 35, U.S.C. § 101, et… federal question jurisdiction over Gensetix’s patent infringement claims and supplemental jurisdiction…indispensable party to at least Gensetix’s claims of patent infringement and cannot be joined due to lack of External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Medtronic
Harvard Business School
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.